Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia

BackgroundAlthough chronic urticaria (CU) is a common, cause of medical consulting both in general practitioners and allergist specialists worldwide, there is little information about its behavior and management in Latin America. Currently, national and international guidelines recommend using Omali...

Full description

Bibliographic Details

Published in:	Frontiers in Allergy
Main Authors:	Elizabeth García-Gómez, Edgardo Chapman, María Beatriz García-Paba, Jaime Ocampo-Gómez, Eduardo Egea-Bermejo, Gloria Garavito-De Egea, Luis Fang, Mauricio Sarrazola, Jorge Mario Sánchez-Caraballo, Carlos Serrano-Reyes, Diana Lucia Silva-Espinosa, Dolly Vanessa Rojas-Mejía, Sergio M. Moreno
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Subjects:	urticaria angioedema Omalizumab inducible antihistamines
Online Access:	https://www.frontiersin.org/articles/10.3389/falgy.2022.902344/full